Long-Term Outcomes and Risk Factors for Mortality in a Cohort of HIV-Infected Children Receiving Antiretroviral Therapy in Vietnam

References

• UNAIDS. Global HIV & AIDS statistics-2019 fact sheet. Available from: https://www.unaids.org/en/resources/fact-sheet. Accessed 722, 2020.
   Google Scholar
• UNAIDS. UNAIDS data 2018; 2018 Available from: https://www.unaids.org/sites/default/files/media_asset/unaids-data-2018_en.pdf. Accessed 722, 2020.
   Google Scholar
• Goetghebuer T, Haelterman E, Le Chenadec J, et al. European infant collaboration group. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS. 2009;23(5):597–604. doi:10.1097/QAD.0b013e328326ca3719194272
   PubMedGoogle Scholar
• Violari A, Cotton MF, Gibb DM, et al. CHer study team. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359(21):2233–2244. doi:10.1056/NEJMoa080097119020325
   PubMed Web of Science ®Google Scholar
• Nguyen DB, Do NT, Shiraishi RW, et al. Outcomes of antiretroviral therapy in Vietnam: results from a national evaluation. PLoS One. 2013;8(2):e55750. doi:10.1371/journal.pone.005575023457477
   PubMed Web of Science ®Google Scholar
• Thuy TT, Shah NS, Anh MH, et al. HIV-associated TB in An Giang Province, Vietnam, 2001–2004: epidemiology and TB treatment outcomes. PLoS One. 2007;2(6):e507. doi:10.1371/journal.pone.000050717551587
   PubMedGoogle Scholar
• Lumbiganon P, Kosalaraksa P, Bunupuradah T, et al. HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes. Asian Biomed (Res Rev News). 2016;10(3):229–234.28239430
   PubMedGoogle Scholar
• Moy FS, Fahey P, Nik Yusoff NK, Razali KA, Nallusamy R, Asia Pediatric TREAT. HIV observational database (TApHOD) outcomes of human immunodeficiency virus-infected children after anti-retroviral therapy in Malaysia. J Paediatr Child Health. 2015;51(2):204–208. doi:10.1111/jpc.1271225142757
   PubMedGoogle Scholar
• Zhao Y, Li C, Sun X, et al. Mortality and treatment outcomes of China’s national pediatric antiretroviral therapy program. Clin Infect Dis. 2013;56(5):735–744. doi:10.1093/cid/cis94123175558
   PubMed Web of Science ®Google Scholar
• Nimkar S, Valvi C, Kadam D, et al. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India. HIV Med. 2018;19(6):395–402. doi:10.1111/hiv.1260529573312
   PubMedGoogle Scholar
• Sophan S, Meng CY, Pean P, et al. Virologic and immunologic outcomes in HIV-infected Cambodian children after 18 months of highly active Antiretroviral therapy (HAART). Southeast Asian J Trop Med Public Health. 2010;41(1):126–137.20578491
   PubMed Web of Science ®Google Scholar
• Bartlett AW, Truong KH, Songtaweesin WN, et al. Characteristics, mortality and outcomes at transition for adolescents with perinatal HIV infection in Asia. AIDS. 2018;32(12):1689–1697. doi:10.1097/QAD.000000000000188329794827
   PubMedGoogle Scholar
• Marcy O, Tejiokem M, Msellati P, et al. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Lancet HIV. 2018;5(2):e87–e95. doi:10.1016/S2352-3018(17)30206-029174612
   PubMed Web of Science ®Google Scholar
• Pham HV, Ishizaki A, Nguyen LV, et al. Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam. Int J STD AIDS. 2015;26(11):821–830. doi:10.1177/095646241455632825332224
   PubMedGoogle Scholar
• Dang MD, Nguyen DM, Tran HB, et al. Clinical characteristics of pediatric HIV-1 patients treated with first-line antiretroviral therapy in Vietnam: a nested case-control study. Int J Public Health. 2017;62(Suppl 1):113–119. doi:10.1007/s00038-016-0937-228160044
   PubMedGoogle Scholar
• Dang VPL, Pham VH, Dinh TT, Le TH, Nguyen VL, Vu TP. Growth in children infected with HIV receiving anti-retroviral therapy in Vietnam. Pediatr Int. 2019;61(4):369–374. doi:10.1111/ped.1380030742346
   PubMedGoogle Scholar
• WHO. Antiretroviral therapy for HIV infection in adult and adolescents; 2006 Available from: https://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf. Accessed 42, 2020.
   Google Scholar
• Vietnam Ministry of Health. Guidelines for HIV/AIDS Diagnosis and Treatment. Hanoi: Vietnam Ministry of Health; 2017.
   Google Scholar
• Vietnam Ministry of Health. Guidelines for HIV/AIDS Diagnosis and Treatment. Hanoi: Vietnam Ministry of Health; 2015.
   Google Scholar
• WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. 2nd ed. Geneva, Switzerland: WHO; 2016.
   Google Scholar
• WHO. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, Switzerland: WHO Library Cataloging-in-Publication Data; 2007 Available from: https://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf?ua=1. Accessed 403, 2019.
   Google Scholar
• WHO. Nutrition landscape information system (NLIS); 2010 Available from: https://www.who.int/nutrition/nlis_interpretation_guide.pdf. Accessed 42, 2010.
   Google Scholar
• De Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660–667. doi:10.2471/BLT.07.04349718026621
   PubMed Web of Science ®Google Scholar
• Dusingize JC, Hoover DR, Shi Q, et al. Association of abnormal liver function parameters with HIV serostatus and CD4 count in antiretroviral-naive Rwandan women. AIDS Res Hum Retroviruses. 2015;31(7):723–730. doi:10.1089/aid.2014.017025924728
   PubMed Web of Science ®Google Scholar
• Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME. Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa. PLoS One. 2011;6(7):e22706. doi:10.1371/journal.pone.002270621829487
   PubMedGoogle Scholar
• Gebremedhin A, Gebremariam S, Haile F, Weldearegawi B, Decotelli C. Predictors of mortality among HIV infected children on anti-retroviral therapy in Mekelle Hospital, Northern Ethiopia: a retrospective cohort study. BMC Public Health. 2013;6(13):1047. doi:10.1186/1471-2458-13-1047
   Web of Science ®Google Scholar
• Koye DN, Ayele TA, Zeleke BM. Predictors of mortality among children on antiretroviral therapy at a referral hospital, Northwest Ethiopia: a retrospective follow up study. BMC Pediatr. 2012;12(1):161. doi:10.1186/1471-2431-12-16123043325
   PubMedGoogle Scholar
• Mutanga JN, Mutembo S, Ezeamama AE, et al. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003–2015). BMC Public Health. 2019;19(1):115. doi:10.1186/s12889-019-6444-730691416
   PubMedGoogle Scholar
• Shabangu P, Beke A, Manda S, Mthethwa N, Mthethwa N. Predictors of survival among HIV-positive children on ART in Swaziland. Afr J AIDS Res. 2017;16(4):335–343. doi:10.2989/16085906.2017.138621929132283
   PubMed Web of Science ®Google Scholar
• Kabue MM, Buck WC, Wanless SR, et al. Mortality and clinical outcomes in HIV-infected children on antiretroviral therapy in Malawi, Lesotho, and Swaziland. Pediatrics. 2012;130(3):e591–9. doi:10.1542/peds.2011-118722891234
   PubMed Web of Science ®Google Scholar
• Anigilaje EA, Aderibigbe SA. Mortality in a cohort of HIV-infected children: a 2-month outcome of antiretroviral therapy in Makurdi, Nigeria. Adv Med. 2018;9:6409134.
   Google Scholar
• Wamalwa DC, Obimbo EM, Farquhar C, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr. 2010;18(10):33.
   Web of Science ®Google Scholar
• Ebonyi AO, Oguche S, Meloni ST, et al. Predictors of mortality in a clinic cohort of HIV-1 infected children initiated on antiretroviral therapy in Jos, Nigeria. J AIDS Clin Res. 2014;5(12):403.30416842
   PubMedGoogle Scholar
• Phongsamart W, Hansudewechakul R, Bunupuradah T, et al. Long-term outcomes of HIV-infected children in Thailand: the Thailand pediatric HIV observational database. Int J Infect Dis. 2014;22:19–24. doi:10.1016/j.ijid.2013.12.01124576843
   PubMedGoogle Scholar
• Lolekha R, Anuwatnonthakate A, Nateniyom S, et al. Childhood TB epidemiology and treatment outcomes in Thailand: a TB active surveillance network, 2004 to 2006. BMC Infect Dis. 2008;18(8):94. doi:10.1186/1471-2334-8-94
   Web of Science ®Google Scholar
• Mwiru RS, Spiegelman D, Duggan C, et al. Nutritional status and other baseline predictors of mortality among HIV-infected children initiating antiretroviral therapy in Tanzania. J Int Assoc Provid AIDS Care. 2015;14(2):172–179. doi:10.1177/232595741350085224106055
   PubMedGoogle Scholar
• Bassett IV, Chetty S, Wang B, et al. Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa. J Acquir Immune Defic Syndr. 2012;59(1):25–30. doi:10.1097/QAI.0b013e31823d3aba22027877
   PubMedGoogle Scholar
• Mu W, Bartlett AW, Bunupuradah T, et al. Early and late virologic failure after virologic suppression in HIV-infected asian children and adolescents. J Acquir Immune Defic Syndr. 2019;80(3):308–315. doi:10.1097/QAI.000000000000192130531299
   PubMedGoogle Scholar
• Costenaro P, Penazzato M, Lundin R, et al. Predictors of treatment failure in hiv-positive children receiving combination antiretroviral therapy: cohort data from Mozambique and Uganda. J Pediatric Infect Dis Soc. 2015;4(1):39–48. doi:10.1093/jpids/piu03226407356
   PubMedGoogle Scholar
• Assefa A, Gelaw B, Getnet G, Yitayew G. The effect of incident tuberculosis on immunological response of HIV patients on highly active antiretroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2014;14:468.25164855
   PubMed Web of Science ®Google Scholar
• Kaung Nyunt KK, Han WW, Satyanarayana S, et al. Factors associated with death and loss to follow-up in children on antiretroviral care in mingalardon specialist hospital, Myanmar, 2006–2016. PLoS One. 2018;13(4):e0195435. doi:10.1371/journal.pone.019543529621302
   PubMedGoogle Scholar
• Soeters HM, Napravnik S, Patel MR, Eron JJ Jr, Van Rie A. The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy: a systematic review. AIDS. 2014;28(2):245–255. doi:10.1097/01.aids.0000434936.57880.cd24072197
   PubMedGoogle Scholar
• Collins IJ, Jourdain G, Hansudewechakul R, et al. Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study. Clin Infect Dis. 2010;51(12):1449–1457. doi:10.1086/65740121054181
   PubMedGoogle Scholar
• Anaky MF, Duvignac J, Wemin L, et al. Scaling up antiretroviral therapy for HIV-infected children in Côte d’Ivoire: determinants of survival and loss to programme. Bull World Health Organ. 2010;88(7):490–499. doi:10.2471/BLT.09.06801520616968
   PubMedGoogle Scholar
• Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298(16):1888–1899. doi:10.1001/jama.298.16.188817954540
   PubMed Web of Science ®Google Scholar
• Bong CN, Yu JK, Chiang HC, et al. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS. 2007;21(13):1805–1810. doi:10.1097/QAD.0b013e3282c3a9e417690580
   PubMed Web of Science ®Google Scholar
• Fenner L, Brinkhof MW, Keiser O, et al. International epidemiologic databases to evaluate AIDS in Southern Africa. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr. 2010;54(5):524–532. doi:10.1097/QAI.0b013e3181e0c4cf20588185
   PubMed Web of Science ®Google Scholar
• Musoke PM, Mudiope P, Barlow-Mosha LN, et al. Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study. BMC Pediatr. 2010;10(1):56. doi:10.1186/1471-2431-10-5620691045
   PubMed Web of Science ®Google Scholar
• Peacock-Villada E, Richardson BA, John-Stewart GC, John-Stewart GC . Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics. 2011;127(2):e423–41. doi:10.1542/peds.2009-270121262891
   PubMed Web of Science ®Google Scholar
• Biru M, Hallström I, Lundqvist P, Jerene D, Paraskevis D. Rates and predictors of attrition among children on antiretroviral therapy in Ethiopia: a prospective cohort study. PLoS One. 2018;13(2):e0189777. doi:10.1371/journal.pone.018977729408897
   PubMedGoogle Scholar
• Ebissa G, Deyessa N, Biadgilign S. Predictors of early mortality in a cohort of HIV-infected children receiving highly active antiretroviral treatment in public hospitals in Ethiopia. AIDS Care. 2015;27(6):723–730. doi:10.1080/09540121.2014.99718025599414
   PubMed Web of Science ®Google Scholar